Artesunate-mefloquine
Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children
13
Pharmacokinetic interactions between artesunate mefloquine and ritonavir boosted lopinavir in healthy Thai adults
13
Failure of artesunate mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia
9
Artesunate mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety
9
Population pharmacokinetics of mefloquine, administered as a fixed dose combination of artesunate mefloquine in Indian patients for the treatment of acute uncomplicated Plasmodium falciparum malaria
7
Efficacy, safety and tolerability of artesunate mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria
9
The story of artesunate–mefloquine (ASMQ), innovative partnerships in drug development: case study
10
Effect of artesunate mefloquine fixed dose combination in malaria transmission in amazon basin communities
12
The neurological assessment in young children treated with artesunate monotherapy or artesunate mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria
11
Population pharmacokinetics of mefloquine given as a 3 day artesunate–mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug resistant area along the Thai–Myanmar border
9
Compliance with a three day course of artesunate mefloquine combination and baseline anti malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria
8
Declining in efficacy of a three day combination regimen of mefloquine artesunate in a multi drug resistance area along the Thai Myanmar border
10
Clearance Failure Rates of Plasmodium falciparum after Treatment among Children (6 11 years) in Kisumu East Sub County
9
Overestimating resistance in field testing of malaria parasites: simple methods for estimating high EC50 values using a Bayesian approach
9
Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015)
12
Challenges for malaria elimination in Brazil
18
Assessing the utility of an anti malarial pharmacokinetic pharmacodynamic model for aiding drug clinical development
14
A randomized trial of artemether lumefantrine versus mefloquine artesunate for the treatment of uncomplicated multi drug resistant Plasmodium falciparum on the western border of Thailand
6
Mefloquine pharmacokinetics and mefloquine artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria
8
Simultaneous quantification of artesunate and mefloquine in fixed dose combination tablets by multivariate calibration with middle infrared spectroscopy and partial least squares regression
8